at present, xianqiang pharmaceutical co., ltd. has eight dosage forms and eleven production lines, including raw materials, sub-packaged powder injections, freeze-dried powder injections, cephalosporin solids, tablets, capsules, granules and small-volume injections. Categories include antibacterial drugs, antiviral drugs, cardiovascular and cerebrovascular drugs, hepatopathy drugs, gynecological drugs, hemostatic drugs and nutritional supplements. Main products: cefixime dispersible tablets, arabinoside monophosphate for injection, etc.
The company adopts the clinical sales model of regional agency and academic promotion, and has a professional sales team. The sales network covers cities above the county level, with thousands of cooperative dealers. The products have been used by more than 2 provinces, municipalities and autonomous regions, more than 4 prefecture-level cities and more than 1, clinical hospitals. By the end of 212, the company had 26 registered trademarks, among which brands such as "first strong", "first strong and strict", "Jiannaosu" and "first strong and reliable" have been widely rooted in people's hearts and have strong influence. The market share of cefixime dispersible tablets is 11.67%, ranking third in China; The market share of arabinoside monophosphate for injection is 4.25%, ranking first in China; The market share of arabinoside monophosphate and ritodrine is 65% and 5%, respectively, and the two raw materials are in an absolute leading position in China.
guangdong pharmaceutical university Xianqiang New Drug Research Institute has an international standard laboratory area of 2, square meters, including chemical synthesis room, analysis and testing room, pharmaceutical preparation room, biotechnology room, Industry-University-Research office and registration information department, etc., with more than 2 professional researchers, and more than 5 university researchers were introduced through Industry-University-Research cooperation, and Industry-University-Research cooperated with guangdong pharmaceutical university in technical exchange, project cooperation and personnel training. The research institute has been recognized as Guangzhou Enterprise Technology Center, and cooperated with Sun Yat-sen University to build Guangdong Provincial Key Engineering Technology Research and Development Center for Pharmaceutical Preparations. In cooperation with Guangdong Pharmaceutical Society, the Institute led the establishment of the Anti-infection Committee of Guangdong Pharmaceutical Society, and gathered a large number of medical experts in the province to conduct research on infectious pharmacy. Xianqiang New Drug Research Institute was supported by special funds for the development of small and medium-sized enterprises in Guangzhou and Guangdong.
in order to meet the rapidly growing capacity demand of enterprises, the company invested 25 million yuan to build a new high-tech biopharmaceutical base that meets the requirements of cGMP in the European Union. The project covers an area of 17 mu, and 2 production lines, scientific research centers, quality inspection centers, training centers, power centers, environmental protection processing centers, storage and transportation centers and other functional modules in 7 comprehensive workshops, including cephalosporin solid preparations, sterile injections, biological drugs and raw materials. At present, Xianqiang Pharmaceutical is one of the major taxpayers in Conghua City, and this project has been highly valued and strongly supported by the local government.
honesty is the basic idea of the company. Sincere cooperation makes our friends more and more. Love is the company's dedication to the society. In 25, during the flash floods in Hunan and the Wenchuan earthquake in Sichuan, the company carried out donation-losing activities. In the development of global integrated economy in the 21st century, all colleagues of Xianqiang Pharmaceutical firmly believe that with the support and cooperation from all walks of life, we will certainly create a better future.
our enterprise aim is to "make medicines well and spread them around the world".